GMP News and Research

RSS

Construction will enable pSivida to increase BrachySil production

Global nanotechnology company pSivida Limited has announced that it's UK manufacturing partner, Atomising Systems Ltd ("ASL"), has reached a key milestone in the manufacture of BrachySil, its lead product, by completing construction of a state of the art dedicated cleanroom facility to GMP specifications at its Sheffield plant in the United Kingdom. ASL is a world leader in high temperature atomising technology.

30 Mar 2005

Mesoblast moves towards adult stem cell human trials

Exciting Australian adult stem cell company, Mesoblast Limited, today announced that it is set to begin the first human clinical trials using its specialist adult stem cells for orthopaedic and cardiovascular diseases.

30 Mar 2005

UK leads race to produce world’s first clinical grade stem cells

The University of Sheffield has received a £2.6m grant to create some of the world’s first embryonic stem cell lines that can be used for medicinal purposes.

16 Mar 2005

UK will vote against the declaration on human cloning

The UN declaration is non-binding and has no legal status, but it calls on countries to prohibit all forms of human cloning. This is totally unacceptable to the UK government which strongly supports stem cell research, including embryonic stem cell research which involves the use of cloning technology.

8 Mar 2005

Benitec announces AIDS collaboration

Benitec today announced a collaboration with City of Hope (based in Duarte California) to develop a novel T-cell based therapy for AIDS patients.

22 Feb 2005

Separating chromosomes improves genetic test results

A new process that helps unmask genetic mutations by separating chromosomes so they can be studied individually may improve the diagnostic yield of some genetic tests, according to findings of a Colon Cancer Family Registry study published today in the Journal of the American Medical Association.

16 Feb 2005

Mesoblast signs adult stem cells agreement

Australia’s adult stem cell company, Mesoblast Limited, today announced that it had signed an agreement for production of specialised adult stem cells, known as Mesenchymal Precursor Cells (MPCs), to be used in human pilot clinical trials in patients with orthopaedic and cardiovascular diseases.

14 Feb 2005

Stem cells use inflammatory signals to find injured tissue

A joint effort led by stem cell biologist Evan Y. Snyder, M.D., Ph.D., of The Burnham Institute, and Samia J. Khoury, M.D., of Harvard Medical School and Brigham and Women’s Hospital, report data suggesting that stem cells use inflammatory signals to “know” where they must home.

20 Dec 2004

Lupus drug may also be useful in treating psoriasis

A new drug candidate previously shown to reduce harmful side effects of the autoimmune disease lupus also may be useful in treating psoriasis.

13 Dec 2004

Research shows C. botulinum uses SONO to detect nitric oxide

A deadly bacterium's defense against a mortal molecular enemy illuminates the origins and structure of a vital protein involved in human cell signaling, University of Texas Medical School scientists report in Science Express.

8 Oct 2004

Oxford Therapeutic Antibody Centre receives Manufacturer’s Authorisation

Oxford University's Therapeutic Antibody Centre (TAC) has received a Manufacturer's Authorisation (Investigational Medicinal Products) from the Medicines and Healthcare Products Regulatory Agency (MHRA).

29 Jun 2004

WHO removes two antiretroviral products from the WHO List of prequalified products

The World Health Organization (WHO) removed two antiretroviral products from the WHO List of prequalified products

20 Jun 2004

Conflicting views on embryonic and adult stem cells complicate research in stem cell therapeutics

Though there has been considerable biological and political debate over the use of embryonic stem cells (ESCs) vs. adult stem cells (ASCs) as therapies for tissue engineering and organ transplants, inherent benefits and drawbacks in both techniques compel them to coexist and complement each other.

10 Jun 2004

First Consulting Group announces expansion of relationship with AstraZeneca

First Consulting Group, Inc. has announced that it has expanded its long-standing relationship with AstraZeneca. FCG will help AstraZeneca deliver a new off-the-shelf document management solution and upgrade its manufacturing site document management system to FirstDoc™.

2 Jun 2004

Cordis Cardiology receives warning from the U.S. Food and Drug Administration

Cordis Cardiology, a division of Cordis Corporation, a Johnson & Johnson Company, reported today that it received a warning letter from the U.S. Food and Drug Administration (FDA) regarding FDA's observations concerning the Good Manufacturing Practice (GMP) regulations.

5 Apr 2004

New center enables genetic treatments and advances

A new state-of-the-art research facility dedicated to helping produce modified cells for treatment of cancer and other diseases recently opened at the Siteman Cancer Center.

1 Apr 2004